Literature DB >> 16333983

Developmental regulation and coordinate reexpression of FKBP65 with extracellular matrix proteins after lung injury suggest a specialized function for this endoplasmic reticulum immunophilin.

Charles E Patterson1, William R Abrams, Nikolaus E Wolter, Joel Rosenbloom, Elaine C Davis.   

Abstract

AFKBP65 (65-kDa FK506-binding protein) is an endoplasmic reticulum (ER)-localized peptidyl-prolyl cis-trans isomerase predicted to play a role in the folding and trafficking of secretory proteins. In previous studies, we have shown that FKBP65 is developmentally regulated and associates with the extracellular matrix protein, tropoelastin, during its maturation and transport through the ER. In this study, we show that FKBP65 is expressed in the lung with the same developmental pattern as tropoelastin and other matrix proteins. To test the hypothesis that FKBP65 is upregulated at times when extracellular matrix proteins are being actively synthesized and assembled, adult mice were treated with bleomycin to cause reinitiation of matrix protein production during the ensuing development of pulmonary fibrosis. After bleomycin instillation, FKBP65 expression was reactivated in the lung with a pattern similar to that observed for tropoelastin and type I collagen. Using human lung fibroblast cultures, we showed that FKBP65 does not undergo the unfolded protein response, a response associated with an upregulation of resident ER proteins that occurs after increased ER stress. When fibroblasts were treated with transforming growth factor (TGF)-beta1, which is upregulated during the development of pulmonary fibrosis and known to induce matrix production, FKBP65 expression and synthesis was also increased. Similar to type I collagen and tropoelastin, this response was completely inhibited in a dose-dependent manner by GGTI-298, a geranylgeranyl transferase I inhibitor. Treatment of fibroblasts with an inhibitor of ribonucleic acid (RNA) polymerase II after TGF-beta1 treatment showed that the effect of TGF-beta1 was not because of increased stabilization of the FKBP65 messenger RNA. In summary, we have shown that FKBP65 is highly expressed in lung development, downregulated in the adult, and can be reactivated in a coordinated manner with extracellular matrix proteins after lung injury. The expression pattern of FKBP65, which is atypical for general ER foldases, suggests that FKBP65 has a distinct set of developmentally regulated protein ligands. The response to injury, which may be in part a direct response to TGF-beta1, assures the presence of FKBP65 in the ER of cells actively producing components of the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333983      PMCID: PMC1283874          DOI: 10.1379/csc-118r.1

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  51 in total

Review 1.  Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones.

Authors:  S R Lamandé; J F Bateman
Journal:  Semin Cell Dev Biol       Date:  1999-10       Impact factor: 7.727

2.  Hsp47: a molecular chaperone that interacts with and stabilizes correctly-folded procollagen.

Authors:  M Tasab; M R Batten; N J Bulleid
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

3.  Aspects of gene regulation during the UPR in human cells.

Authors:  C Benedetti; M Fabbri; R Sitia; A Cabibbo
Journal:  Biochem Biophys Res Commun       Date:  2000-11-30       Impact factor: 3.575

4.  Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38.

Authors:  Umberto Kucich; Joan C Rosenbloom; William R Abrams; Joel Rosenbloom
Journal:  Am J Respir Cell Mol Biol       Date:  2002-02       Impact factor: 6.914

5.  TGF-beta is a critical mediator of acute lung injury.

Authors:  J F Pittet; M J Griffiths; T Geiser; N Kaminski; S L Dalton; X Huang; L A Brown; P J Gotwals; V E Koteliansky; M A Matthay; D Sheppard
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

6.  Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin.

Authors:  T Betsuyaku; Y Fukuda; W C Parks; J M Shipley; R M Senior
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

7.  Impaired distal airway development in mice lacking elastin.

Authors:  D P Wendel; D G Taylor; K H Albertine; M T Keating; D Y Li
Journal:  Am J Respir Cell Mol Biol       Date:  2000-09       Impact factor: 6.914

8.  Differential interaction of molecular chaperones with procollagen I and type IV collagen in corneal endothelial cells.

Authors:  MinHee K Ko; EunDuck P Kay
Journal:  Mol Vis       Date:  2002-01-11       Impact factor: 2.367

9.  Developmental regulation of FKBP65. An ER-localized extracellular matrix binding-protein.

Authors:  C E Patterson; T Schaub; E J Coleman; E C Davis
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

10.  Elastin gene expression is upregulated during pulmonary fibrosis.

Authors:  C R Hoff; D R Perkins; J M Davidson
Journal:  Connect Tissue Res       Date:  1999       Impact factor: 3.417

View more
  13 in total

1.  FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.

Authors:  Claudia A Staab-Weijnitz; Isis E Fernandez; Larissa Knüppel; Julia Maul; Katharina Heinzelmann; Brenda M Juan-Guardela; Elisabeth Hennen; Gerhard Preissler; Hauke Winter; Claus Neurohr; Rudolf Hatz; Michael Lindner; Jürgen Behr; Naftali Kaminski; Oliver Eickelberg
Journal:  Am J Respir Crit Care Med       Date:  2015-08-15       Impact factor: 21.405

Review 2.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

3.  Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay.

Authors:  Omar Massoud; Julie Heimbach; Kimberly Viker; Anuradha Krishnan; John Poterucha; William Sanchez; Kymberly Watt; Russell Wiesner; Michael Charlton
Journal:  Liver Transpl       Date:  2011-06       Impact factor: 5.799

4.  Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta.

Authors:  Yasemin Alanay; Hrispima Avaygan; Natalia Camacho; G Eda Utine; Koray Boduroglu; Dilek Aktas; Mehmet Alikasifoglu; Ergul Tuncbilek; Diclehan Orhan; Filiz Tiker Bakar; Bernard Zabel; Andrea Superti-Furga; Leena Bruckner-Tuderman; Cindy J R Curry; Shawna Pyott; Peter H Byers; David R Eyre; Dustin Baldridge; Brendan Lee; Amy E Merrill; Elaine C Davis; Daniel H Cohn; Nurten Akarsu; Deborah Krakow
Journal:  Am J Hum Genet       Date:  2010-04-01       Impact factor: 11.025

5.  Endoplasmic reticulum stress or mutation of an EF-hand Ca(2+)-binding domain directs the FKBP65 rotamase to an ERAD-based proteolysis.

Authors:  Lindsey A Murphy; Emily A Ramirez; Van T Trinh; Alexander M Herman; Valen C Anderson; Jay L Brewster
Journal:  Cell Stress Chaperones       Date:  2011-07-15       Impact factor: 3.667

6.  Expression of FK506 binding protein 65 (FKBP65) is decreased in epithelial ovarian cancer cells compared to benign tumor cells and to ovarian epithelium.

Authors:  Rudi Henriksen; Flemming Brandt Sørensen; Torben Falck Ørntoft; Karin Birkenkamp-Demtroder
Journal:  Tumour Biol       Date:  2011-03-12

7.  Heat shock protein 47 and 65-kDa FK506-binding protein weakly but synergistically interact during collagen folding in the endoplasmic reticulum.

Authors:  Yoshihiro Ishikawa; Paul Holden; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

8.  Connective tissue alterations in Fkbp10-/- mice.

Authors:  Caressa D Lietman; Abbhirami Rajagopal; Erica P Homan; Elda Munivez; Ming-Ming Jiang; Terry K Bertin; Yuqing Chen; John Hicks; MaryAnn Weis; David Eyre; Brendan Lee; Deborah Krakow
Journal:  Hum Mol Genet       Date:  2014-04-28       Impact factor: 6.150

Review 9.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

10.  Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations.

Authors:  Aileen M Barnes; Geraldine Duncan; Maryann Weis; William Paton; Wayne A Cabral; Edward L Mertz; Elena Makareeva; Michael J Gambello; Felicitas L Lacbawan; Sergey Leikin; Andrzej Fertala; David R Eyre; Sherri J Bale; Joan C Marini
Journal:  Hum Mutat       Date:  2013-07-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.